- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00474682
Relative Bioavailability of Ferric Pyrophosphate From an Apple Juice Drink
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Micronized dispersible ferric pyrophosphate (MDFP) is an iron compound that has been reported to be highly bioavailable and likely to cause few sensory problems when added to food. It is therefore a potentially effective iron additive for the food industry and is particularly formulated for adding to liquids. A randomized cross-over trial will be undertaken to compare the absorption of iron added to a commercial apple juice drink as MDFP with iron added as ferrous sulphate. The null hypothesis is that absorption of iron added as MDFP is not different to absorption from iron added as ferrous sulphate.
The study population will consist of 16 women (age 18-65) with iron stores at the lower end of the normal range. This group will efficiently absorb bioavailable iron and will be sensitive to differences in bioavailability between different forms of iron. Test drinks containing added iron, labelled with stable isotopes of iron (Fe-57 or Fe-58), will be consumed on two consecutive days. Iron absorption from the drinks will be determined using the erythrocyte incorporation technique. A baseline blood sample will be taken prior to consuming the test drinks and then a second blood sample will be taken 14 days after the last test drink. Iron absorption will be calculated from the isotopic enrichment of the final blood sample, assuming that 80% of absorbed iron is incorporated into red blood cells. The order in which the volunteers will be given the MDFP or ferrous sulphate will be randomised.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Norfolk
-
Norwich, Norfolk, United Kingdom, NR4 6JF
- Institute of Food Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women
- Age >18 and <65
- BMI >18.5 and <35
- Serum ferritin value of =12μg/L and =50μg/L
Exclusion Criteria:
- Men
- Age < 18 or >65
- BMI <18.5 or >35
- Serum ferritin value of <12μg/L or >50μg/L
- Volunteers will be excluded if they are found to have depressed or elevated blood pressure measurements (<90/50 or<95/50 if symptomatic or >160/100)
- Diagnosed with a long-term illness requiring active treatment, e.g. diabetes, cancer, cardiovascular disease
- Gastrointestinal disease (excluding hiatus hernia unless symptomatic)
- Regular prescribed medication that may interfere with iron metabolism
- Regular use of antacids and laxatives (at least once a week)
- Women who are pregnant or less than 12 months since giving birth
- Women breast feeding
- Vitamin supplements with or without minerals if taken more than once a week, and unwillingness to discontinue occasional use for the duration of study
- Unwillingness to discontinue use of herbal supplements for the duration of study
- Use of antibiotics within four weeks prior to study start
- Parallel participation in another study which involves dietary interventions or sampling of blood that may increase the volume taken above 500ml in a 4-month period.
- Asthma requiring treatment within the last two years
- Results of clinical screening which indicate, or are judged by the HNU Medical advisor to be indicative of a health problem which could compromise the well-being of the volunteer if they participated or which would affect the study data.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Relative bioavailability of Micronized dispersible ferric pyrophosphate added to apple juice
Time Frame: 18 months
|
18 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Susan J Fairweather-Tait, University of East Anglia
Study record dates
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IFR04/2006
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iron Deficiency
-
Tampere University HospitalTampere UniversityRecruitingIron Deficiency | Iron Deficiency Anaemia in Childbirth | Iron Status | Iron Deficiency in Pregnancy | Iron Deficiency Anemia in PregnancyFinland
-
Pennington Biomedical Research CenterCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency Anemia TreatmentUnited States
-
King's CollegeCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)United States
-
Children's Hospital Los AngelesNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingAnemia | Iron Deficiency Anemia | Anemia, Iron Deficiency | IDA - Iron Deficiency AnemiaUnited States
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); Syracuse University; Liverpool... and other collaboratorsCompletedIron-deficiency | Iron-deficiency AnemiaGhana
-
Ain Shams UniversityActive, not recruitingIron Deficiency Anemia TreatmentEgypt
-
Antalya Training and Research HospitalCompletedIron Deficiency Anemia | Iron Deficiency Anemia TreatmentTurkey
-
University of MinnesotaUniversity of HawaiiCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)United States
-
University of Lagos, NigeriaAminu Kano Teaching HospitalCompletedIron Deficiency Anemia of PregnancyNigeria
-
Sohag UniversityActive, not recruiting
Clinical Trials on Micronized dispersible ferric pyrophosphate
-
Federal University of Juiz de ForaUnknownAnemia | Bowel Diseases, Inflammatory
-
Rockwell Medical Technologies, Inc.CompletedKidney Failure, Chronic Therapy; HemodialysisUnited States
-
Swiss Federal Institute of TechnologyPATHCompleted
-
Iowa State UniversityCompleted
-
Rockwell Medical Technologies, Inc.CompletedKidney FailureUnited States
-
Swiss Federal Institute of TechnologyUniversity for Development Studies, Tamale, GhanaCompletedIron Deficiency and/or AnemiaSwitzerland, Ghana
-
Rockwell Medical Technologies, Inc.CompletedEnd Stage Renal DiseaseUnited States
-
Rockwell Medical Technologies, Inc.CompletedRenal Failure Chronic Requiring HemodialysisUnited States, Puerto Rico
-
Rockwell Medical Technologies, Inc.CompletedRenal Failure Chronic Requiring HemodialysisUnited States, Canada
-
Rockwell Medical Technologies, Inc.CompletedEnd Stage Renal DiseaseUnited States